Eversept Partners’s Labcorp LH Stock Holding History

Eversept Partners’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,419	Closed	-$1.48M	–	73
2022 Q3	$1.48M	Buy	8,419 +2,187	+35%	+$448K	0.13%	54
2022 Q2	$1.25M	Sell	6,232 -37,895	-86%	-$8.08M	0.09%	61
2022 Q1	$10M	Sell	44,127 -8,861	-17%	-$2.08M	0.77%	34
2021 Q4	$14.3M	Sell	52,988 -96,366	-65%	-$23.9M	0.91%	32
2021 Q3	$36.1M	Buy	+149,354	New	+$37.6M	2.5%	14

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Eversept Partners's LH Position: Q4 2022 in Review

Eversept Partners sold out of Labcorp (LH) in Q4 2022, closing a stake of 8,419 shares — an estimated $1.48M sold.

Eversept Partners first reported a position in LH in Q3 2021 and held it in 5 quarters. The position peaked at $36.1M in Q3 2021. 970 funds tracked by Wall St. Rank hold LH as of Q4 2022.

Eversept Partners reported no remaining Labcorp position as of Q4 2022 after selling out during the quarter.
Eversept Partners sold 8,419 Labcorp shares in Q4 2022, an estimated $1.48M.
Eversept Partners first reported a position in Labcorp in Q3 2021 and held it in 5 quarters.
Eversept Partners's Labcorp position peaked at $36.1M in Q3 2021.
970 funds tracked by Wall St. Rank held Labcorp as of Q4 2022.

Based on Eversept Partners's 13F filing for Q4 2022, filed 14 Feb 2023.